Cisapride Monohydrate

西沙必利

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCisapride Monohydrate
Drug Alias NameCisapridum西沙比利单水合西沙必利普瑞博思西沙比利-水合物 +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsGastrointestinal motility disordersDiabetic GastroparesisDyspepsia +[5] 
Global Approved IndicationsGastrointestinal motility disordersDiabetic GastroparesisDyspepsia +[5] 
Approved Indications in ChinaDiabetic GastroparesisIntestinal Pseudo-ObstructionGastroesophageal Reflux
Original Approved Country/TerritoryUnited States
Original Approved Date1993/07/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesXian Janssen Pharmaceutical Ltd
Inactive CompaniesJanssen Pharmaceuticals Inc
Active IndicationsDiabetic GastroparesisIntestinal Pseudo-ObstructionGastroesophageal Reflux
Inactive IndicationsGastrointestinal motility disordersDyspepsia

Other Information

ATC CodeA03FA02
Related LinksWikipediaDrugBankKEGG